Loading…

Effect of coenzyme Q10 on cardiac function and survival in heart failure: an overview of systematic reviews and -analyses

Heart failure (HF) is associated with a deficiency in blood levels of coenzyme Q10 (CoQ10), and its supplementation has been proposed. The aim of this systematic review was to synthesise the available evidence on the effects of CoQ10 on cardiac function and quality of life in HF. A systematic search...

Full description

Saved in:
Bibliographic Details
Published in:Food & function 2023-07, Vol.14 (14), p.632-6311
Main Authors: Alarcón-Vieco, Eva, Martínez-García, Irene, Sequí-Domínguez, Irene, Rodríguez-Gutiérrez, Eva, Moreno-Herráiz, Nerea, Pascual-Morena, Carlos
Format: Article
Language:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 6311
container_issue 14
container_start_page 632
container_title Food & function
container_volume 14
creator Alarcón-Vieco, Eva
Martínez-García, Irene
Sequí-Domínguez, Irene
Rodríguez-Gutiérrez, Eva
Moreno-Herráiz, Nerea
Pascual-Morena, Carlos
description Heart failure (HF) is associated with a deficiency in blood levels of coenzyme Q10 (CoQ10), and its supplementation has been proposed. The aim of this systematic review was to synthesise the available evidence on the effects of CoQ10 on cardiac function and quality of life in HF. A systematic search of Medline, Scopus, Web of Science and the Cochrane Library was conducted from inception until March 2023. Meta -analyses measuring the effect of CoQ10 on cardiac function [ i.e. , ejection fraction (EF), cardiac output (CO), cardiac index (CI), stroke volume (SV)], quality of life [ i.e. , mortality, exercise capacity, and New York Heart Association (NYHA) classification], and CoQ10 levels in HF were included. Ten meta -analyses met the inclusion criteria. CoQ10 had an effect on EF in 6 of the 9 studies, with an increase of 1.77% (0.10, 3.44) to 3.81% (1.22, 6.40), while it had an effect on CO, CI and SV in one of the two studies. Moreover, CoQ10 did not improve exercise capacity and only one study showed an effect on NYHA classification, while there was a risk ratio (RR) of 0.69 (0.50, 0.95) to 0.58 (0.35, 0.95) in favour of CoQ10 for mortality and a RR of 0.62 (0.49, 0.78) for hospitalisations. Finally, CoQ10 levels were found to increase by 1.40 μg mL −1 in all studies. CoQ10 showed a possible beneficial effect on heart function, which was associated with a reduction in mortality and hospitalisations. However, more research is needed into the conditions that may optimise CoQ10 therapy. Heart failure (HF) is associated with a deficiency in blood levels of coenzyme Q10 (CoQ10), and its supplementation has been proposed.
doi_str_mv 10.1039/d3fo01255g
format article
fullrecord <record><control><sourceid>rsc</sourceid><recordid>TN_cdi_rsc_primary_d3fo01255g</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>d3fo01255g</sourcerecordid><originalsourceid>FETCH-rsc_primary_d3fo01255g3</originalsourceid><addsrcrecordid>eNqFj0FrAjEUhINUUKoX78L7A9tmd10xXsXSa6EHb_LIvmhkN5G87Er89V1LS4-dywzzwcAIscjlSy5L9VqXxsu8qKrTSEwLuSqydSUPT795pdYTMWe-yEGlUhu1mYq0N4Z0BG9Ae3L31BJ85BK8A42htqjBdE5HOxToauAu9LbHBqyDM2GIYNA2XaDtgMH3NGC6PeY4caQWo9UQ6FHy90CGDpvExDMxNtgwzX_8WSzf9p-79yywPl6DbTGk49-l8j_-BfjhUGw</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effect of coenzyme Q10 on cardiac function and survival in heart failure: an overview of systematic reviews and -analyses</title><source>Royal Society of Chemistry:Jisc Collections:Royal Society of Chemistry Read and Publish 2022-2024 (reading list)</source><creator>Alarcón-Vieco, Eva ; Martínez-García, Irene ; Sequí-Domínguez, Irene ; Rodríguez-Gutiérrez, Eva ; Moreno-Herráiz, Nerea ; Pascual-Morena, Carlos</creator><creatorcontrib>Alarcón-Vieco, Eva ; Martínez-García, Irene ; Sequí-Domínguez, Irene ; Rodríguez-Gutiérrez, Eva ; Moreno-Herráiz, Nerea ; Pascual-Morena, Carlos</creatorcontrib><description>Heart failure (HF) is associated with a deficiency in blood levels of coenzyme Q10 (CoQ10), and its supplementation has been proposed. The aim of this systematic review was to synthesise the available evidence on the effects of CoQ10 on cardiac function and quality of life in HF. A systematic search of Medline, Scopus, Web of Science and the Cochrane Library was conducted from inception until March 2023. Meta -analyses measuring the effect of CoQ10 on cardiac function [ i.e. , ejection fraction (EF), cardiac output (CO), cardiac index (CI), stroke volume (SV)], quality of life [ i.e. , mortality, exercise capacity, and New York Heart Association (NYHA) classification], and CoQ10 levels in HF were included. Ten meta -analyses met the inclusion criteria. CoQ10 had an effect on EF in 6 of the 9 studies, with an increase of 1.77% (0.10, 3.44) to 3.81% (1.22, 6.40), while it had an effect on CO, CI and SV in one of the two studies. Moreover, CoQ10 did not improve exercise capacity and only one study showed an effect on NYHA classification, while there was a risk ratio (RR) of 0.69 (0.50, 0.95) to 0.58 (0.35, 0.95) in favour of CoQ10 for mortality and a RR of 0.62 (0.49, 0.78) for hospitalisations. Finally, CoQ10 levels were found to increase by 1.40 μg mL −1 in all studies. CoQ10 showed a possible beneficial effect on heart function, which was associated with a reduction in mortality and hospitalisations. However, more research is needed into the conditions that may optimise CoQ10 therapy. Heart failure (HF) is associated with a deficiency in blood levels of coenzyme Q10 (CoQ10), and its supplementation has been proposed.</description><identifier>ISSN: 2042-6496</identifier><identifier>EISSN: 2042-650X</identifier><identifier>DOI: 10.1039/d3fo01255g</identifier><ispartof>Food &amp; function, 2023-07, Vol.14 (14), p.632-6311</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27900,27901</link.rule.ids></links><search><creatorcontrib>Alarcón-Vieco, Eva</creatorcontrib><creatorcontrib>Martínez-García, Irene</creatorcontrib><creatorcontrib>Sequí-Domínguez, Irene</creatorcontrib><creatorcontrib>Rodríguez-Gutiérrez, Eva</creatorcontrib><creatorcontrib>Moreno-Herráiz, Nerea</creatorcontrib><creatorcontrib>Pascual-Morena, Carlos</creatorcontrib><title>Effect of coenzyme Q10 on cardiac function and survival in heart failure: an overview of systematic reviews and -analyses</title><title>Food &amp; function</title><description>Heart failure (HF) is associated with a deficiency in blood levels of coenzyme Q10 (CoQ10), and its supplementation has been proposed. The aim of this systematic review was to synthesise the available evidence on the effects of CoQ10 on cardiac function and quality of life in HF. A systematic search of Medline, Scopus, Web of Science and the Cochrane Library was conducted from inception until March 2023. Meta -analyses measuring the effect of CoQ10 on cardiac function [ i.e. , ejection fraction (EF), cardiac output (CO), cardiac index (CI), stroke volume (SV)], quality of life [ i.e. , mortality, exercise capacity, and New York Heart Association (NYHA) classification], and CoQ10 levels in HF were included. Ten meta -analyses met the inclusion criteria. CoQ10 had an effect on EF in 6 of the 9 studies, with an increase of 1.77% (0.10, 3.44) to 3.81% (1.22, 6.40), while it had an effect on CO, CI and SV in one of the two studies. Moreover, CoQ10 did not improve exercise capacity and only one study showed an effect on NYHA classification, while there was a risk ratio (RR) of 0.69 (0.50, 0.95) to 0.58 (0.35, 0.95) in favour of CoQ10 for mortality and a RR of 0.62 (0.49, 0.78) for hospitalisations. Finally, CoQ10 levels were found to increase by 1.40 μg mL −1 in all studies. CoQ10 showed a possible beneficial effect on heart function, which was associated with a reduction in mortality and hospitalisations. However, more research is needed into the conditions that may optimise CoQ10 therapy. Heart failure (HF) is associated with a deficiency in blood levels of coenzyme Q10 (CoQ10), and its supplementation has been proposed.</description><issn>2042-6496</issn><issn>2042-650X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqFj0FrAjEUhINUUKoX78L7A9tmd10xXsXSa6EHb_LIvmhkN5G87Er89V1LS4-dywzzwcAIscjlSy5L9VqXxsu8qKrTSEwLuSqydSUPT795pdYTMWe-yEGlUhu1mYq0N4Z0BG9Ae3L31BJ85BK8A42htqjBdE5HOxToauAu9LbHBqyDM2GIYNA2XaDtgMH3NGC6PeY4caQWo9UQ6FHy90CGDpvExDMxNtgwzX_8WSzf9p-79yywPl6DbTGk49-l8j_-BfjhUGw</recordid><startdate>20230717</startdate><enddate>20230717</enddate><creator>Alarcón-Vieco, Eva</creator><creator>Martínez-García, Irene</creator><creator>Sequí-Domínguez, Irene</creator><creator>Rodríguez-Gutiérrez, Eva</creator><creator>Moreno-Herráiz, Nerea</creator><creator>Pascual-Morena, Carlos</creator><scope/></search><sort><creationdate>20230717</creationdate><title>Effect of coenzyme Q10 on cardiac function and survival in heart failure: an overview of systematic reviews and -analyses</title><author>Alarcón-Vieco, Eva ; Martínez-García, Irene ; Sequí-Domínguez, Irene ; Rodríguez-Gutiérrez, Eva ; Moreno-Herráiz, Nerea ; Pascual-Morena, Carlos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-rsc_primary_d3fo01255g3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alarcón-Vieco, Eva</creatorcontrib><creatorcontrib>Martínez-García, Irene</creatorcontrib><creatorcontrib>Sequí-Domínguez, Irene</creatorcontrib><creatorcontrib>Rodríguez-Gutiérrez, Eva</creatorcontrib><creatorcontrib>Moreno-Herráiz, Nerea</creatorcontrib><creatorcontrib>Pascual-Morena, Carlos</creatorcontrib><jtitle>Food &amp; function</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alarcón-Vieco, Eva</au><au>Martínez-García, Irene</au><au>Sequí-Domínguez, Irene</au><au>Rodríguez-Gutiérrez, Eva</au><au>Moreno-Herráiz, Nerea</au><au>Pascual-Morena, Carlos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of coenzyme Q10 on cardiac function and survival in heart failure: an overview of systematic reviews and -analyses</atitle><jtitle>Food &amp; function</jtitle><date>2023-07-17</date><risdate>2023</risdate><volume>14</volume><issue>14</issue><spage>632</spage><epage>6311</epage><pages>632-6311</pages><issn>2042-6496</issn><eissn>2042-650X</eissn><abstract>Heart failure (HF) is associated with a deficiency in blood levels of coenzyme Q10 (CoQ10), and its supplementation has been proposed. The aim of this systematic review was to synthesise the available evidence on the effects of CoQ10 on cardiac function and quality of life in HF. A systematic search of Medline, Scopus, Web of Science and the Cochrane Library was conducted from inception until March 2023. Meta -analyses measuring the effect of CoQ10 on cardiac function [ i.e. , ejection fraction (EF), cardiac output (CO), cardiac index (CI), stroke volume (SV)], quality of life [ i.e. , mortality, exercise capacity, and New York Heart Association (NYHA) classification], and CoQ10 levels in HF were included. Ten meta -analyses met the inclusion criteria. CoQ10 had an effect on EF in 6 of the 9 studies, with an increase of 1.77% (0.10, 3.44) to 3.81% (1.22, 6.40), while it had an effect on CO, CI and SV in one of the two studies. Moreover, CoQ10 did not improve exercise capacity and only one study showed an effect on NYHA classification, while there was a risk ratio (RR) of 0.69 (0.50, 0.95) to 0.58 (0.35, 0.95) in favour of CoQ10 for mortality and a RR of 0.62 (0.49, 0.78) for hospitalisations. Finally, CoQ10 levels were found to increase by 1.40 μg mL −1 in all studies. CoQ10 showed a possible beneficial effect on heart function, which was associated with a reduction in mortality and hospitalisations. However, more research is needed into the conditions that may optimise CoQ10 therapy. Heart failure (HF) is associated with a deficiency in blood levels of coenzyme Q10 (CoQ10), and its supplementation has been proposed.</abstract><doi>10.1039/d3fo01255g</doi><tpages>1</tpages></addata></record>
fulltext fulltext
identifier ISSN: 2042-6496
ispartof Food & function, 2023-07, Vol.14 (14), p.632-6311
issn 2042-6496
2042-650X
language
recordid cdi_rsc_primary_d3fo01255g
source Royal Society of Chemistry:Jisc Collections:Royal Society of Chemistry Read and Publish 2022-2024 (reading list)
title Effect of coenzyme Q10 on cardiac function and survival in heart failure: an overview of systematic reviews and -analyses
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T23%3A22%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-rsc&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20coenzyme%20Q10%20on%20cardiac%20function%20and%20survival%20in%20heart%20failure:%20an%20overview%20of%20systematic%20reviews%20and%20-analyses&rft.jtitle=Food%20&%20function&rft.au=Alarc%C3%B3n-Vieco,%20Eva&rft.date=2023-07-17&rft.volume=14&rft.issue=14&rft.spage=632&rft.epage=6311&rft.pages=632-6311&rft.issn=2042-6496&rft.eissn=2042-650X&rft_id=info:doi/10.1039/d3fo01255g&rft_dat=%3Crsc%3Ed3fo01255g%3C/rsc%3E%3Cgrp_id%3Ecdi_FETCH-rsc_primary_d3fo01255g3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true